1. A comparison of nine calcium ion antagonists and propranolol: Exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris

   • N. S. Khurmi
   • E. B. Raftery

   Originals Pages: 539 - 548

2. Assessment of ‘once daily’ verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording

   • M. Caruana
   • M. Heber
   • E. B. Raftery

   Originals Pages: 549 - 553

3. Action of mifentidine on the secretory response to sham feeding and pentagastrin and on serum gastrin in duodenal ulcer patients

   • G. Bianchi Porro
   • M. Lazzaroni
   • S. Daniotti

   Originals Pages: 555 - 558

4. 7-Ethoxyresorufin deethylase (EROD) in human liver —The effect of alcoholic liver disease

   • K. W. Woodhouse
   • E. Mutch
   • M. D. Rawlins

   Originals Pages: 559 - 562

5. Bioavailability and elimination of nitrendipine in liver disease

   • P. Dylewicz
   • W. Kirch
   • E. E. Ohnhaus

   Originals Pages: 563 - 568

6. Studies on the metabolism of perhexiline in man

   • R. G. Cooper
   • D. A. P. Evans
   • A. H. Price

   Originals Pages: 569 - 576

7. The pharmacokinetics of yohimbine in man

   • J. A. Owen
   • S. L. Nakatsu
   • A. Morales

   Originals Pages: 577 - 582

8. Single oral dose pharmacokinetics of tiapride in patients with Huntington's disease

   • T. Norman
   • E. Chiu
   • M. S. Gregory

   Originals Pages: 583 - 586

9. Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis

   • D. A. Sica
   • T. Comstock
   • F. Eshelman

   Originals Pages: 587 - 591

10. The pharmacokinetics of single high doses of dexamethasone in cancer patients

    • M. E. Brady
    • G. P. Sartiano
    • C. T. Bauguess

    Originals Pages: 593 - 596

11. Pharmacokinetics and pharmacodynamics of radio-labeled iloprost in elderly volunteers

    • W. Krause
    • Th. Krais

    Originals Pages: 597 - 605

12. Disposition of moracizine (ethmozine) in healthy subjects after oral administration of radiolabelled drug

    • D. L. Howrie
    • H. J. Pieniaszek Jr.
    • L. W. Dittert

    Originals Pages: 607 - 610

13. Prescribing digoxin in geriatric units: The unexplained variability in dosage requirements

    • R. J. Dobbs
    • J. P. Royston
    • S. M. Dobbs

    Short Communications Pages: 611 - 614

14. Induction of phase 3 of the migrating motor complex in human small intestine by trimebutine

    • S. Chaussade
    • S. Grandjouan
    • J. F. Henry

    Short Communications Pages: 615 - 618

15. Pharmacokinetics and systemic availability of the antihypertensive agent indoramin and its metabolite 6-hydroxyindoramin in healthy subjects

    • D. M. Pierce
    • S. M. L. Abrams
    • R. A. Franklin

    Short Communications Pages: 619 - 623

16. Bioavailability of disopyramide in normal volunteers using unbound concentration

    • J. Braun
    • F. Sörgel
    • S. Øie

    Short Communications Pages: 625 - 629

17. Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers

    • D. A. Goldstein
    • Y. K. Tan
    • S. J. Soldin

    Short Communications Pages: 631 - 634

18. Differential efficacy of mebendazole and albendazole againstNecator americanus but not forTrichuris trichiura infestations

    • B. R. Holzer
    • F. J. Frey

    Short Communications Pages: 635 - 637

19. Kinetics of disopyramide in decreased hepatic function

    • F. M. Belpaire
    • M. G. Bogaert

    Letter to the Editors Pages: 639 - 639

20. Response from the authors

    • J. Bonde
    • J. P. Kampmann

    Letter to the Editors Pages: 639 - 639

21. Announcements

    Announcement Pages: 640 - 640